Literature DB >> 11799346

Antimicrobial-induced mania (antibiomania): a review of spontaneous reports.

Ahmed Abouesh1, Chip Stone, William R Hobbs.   

Abstract

The authors reviewed reported cases of antibiotic-induced manic episodes by means of a MEDLINE and PsychLit search for reports of antibiotic-induced mania. Unpublished reports were requested from the World Health Organization (WHO) and the Food and Drug Administration (FDA). Twenty-one reports of antimicrobial-induced mania were found in the literature. There were 6 cases implicating clarithromycin, 13 implicating isoniazid, and 1 case each implicating erythromycin and amoxicillin. The WHO reported 82 cases. Of these, clarithromycin was implicated in 23 (27.6%) cases, ciprofloxacin in 12 (14.4%) cases, and ofloxacin in 10 (12%) cases. Cotrimoxazole, metronidazole, and erythromycin were involved in 15 reported manic episodes. Cases reported by the FDA showed clarithromycin and ciprofloxacin to be the most frequently associated with the development of mania. Statistical analysis of the data would not have demonstrated a significant statistical correlative risk and was therefore not undertaken. Patients have an increased risk of developing mania while being treated with antimicrobials. Although this is not a statistically significant risk, physicians must be aware of the effect and reversibility. Further research clearly is required to determine the incidence of antimicrobial-induced mania, the relative risk factors of developing an antimicrobial-induced manic episode among various demographic populations, and the incidence of patients who continue to have persistent affective disorders once the initial episode, which occurs while the patient is taking antibiotics, subsides. The authors elected to name this syndrome "antibiomania."

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799346     DOI: 10.1097/00004714-200202000-00012

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  26 in total

1.  Hypomania with gabapentin.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2005-07

2.  Ofloxacin induced hypomania.

Authors:  Siddharth Sarkar; Sudhir Kumar Khandelwal
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Hallucinations and tremors due to oral therapeutic doses of erythromycin and methylprednisolone.

Authors:  Massimo Gallerani; Benedetta Boari
Journal:  Intern Emerg Med       Date:  2008-02-13       Impact factor: 3.397

4.  The potential for antimicrobials to adversely affect mental state.

Authors:  Leona Lally; Laura Mannion
Journal:  BMJ Case Rep       Date:  2013-07-05

Review 5.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

6.  Ciprofloxacin Induced Antibiomania.

Authors:  Ramdas Sarjerao Ransing; Dipayan Sarkar
Journal:  J Clin Diagn Res       Date:  2016-12-01

7.  Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling.

Authors:  Edyta K Bichler; Courtney C Elder; Paul S García
Journal:  J Neurophysiol       Date:  2016-10-12       Impact factor: 2.714

8.  Manic episode associated with clarithromycin in a patient with medically treated depression.

Authors:  Benjamin Y M Kwan; Kiran Rabheru
Journal:  Prim Care Companion CNS Disord       Date:  2012-03-15

Review 9.  The interplay between the intestinal microbiota and the brain.

Authors:  Stephen M Collins; Michael Surette; Premysl Bercik
Journal:  Nat Rev Microbiol       Date:  2012-09-24       Impact factor: 60.633

10.  Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET.

Authors:  Peter J H Scott; Xia Shao; Timothy J Desmond; Brian G Hockley; Phillip Sherman; Carole A Quesada; Kirk A Frey; Robert A Koeppe; Michael R Kilbourn; Nicolaas I Bohnen
Journal:  ACS Med Chem Lett       Date:  2016-06-01       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.